A FAMILIAL HEMORRHAGIC DIATHESIS IN A DUTCH FAMILY - AN INHERITED DEFICIENCY OF ALPHA-2-ANTIPLASMIN
- 1 January 1982
- journal article
- research article
- Vol. 59 (6) , 1169-1180
Abstract
A case of congenital homozygous deficiency in .alpha.2-antiplasmin associated with a severe hemorrhagic diathesis was studied. Heterozygous family members also showed a mild bleeding tendency. The prospositus was a 17-yr-old male born of white parents and showing a severe hemorrhagic diathesis characterized by spontaneous bleeding in the joints since early childhood. He was originally suspected of having factor XIII deficiency, but was found to have normal functions of the coagulation system and the platelets. Except for .alpha.2-antiplasmin, all protease inhibitors showed normal plasma values. With the immediate plasmin inhibition test (synthetic substrate), only 2% of normal functional inhibition was detected, while no reaction with monospecific antisera for .alpha.2-antiplasmin was observed. Inhibition of activator-induced fibrinolysis in vitro was reduced. No enhanced spontaneous in vitro fibrinolysis was detected nor were there signs of increased in vivo fibrinolysis during an asymptomatic period. During recovery from a hemorrhagic episode, signs of previous consumption of antithrombin III, .alpha.2-macroglobulin, factor XIII and inter-.alpha.-trypsin inhibitor were noted. After the diagnosis was made, treatment with tranexamic acid (4 daily doses of 1 g) was effective for .apprx. 2 yr. Among the 37 family members studied, a separate group of 16 individuals (including the father and mother of the propositus) with .apprx. 1/2 normal plasma levels of .alpha.2-antiplasmin both functionally (59 .+-. 6%) and immunologically (48 .+-. 8%) was discovered. The defect appeared to be inherited as an autosomal recessive gene; no apparent heterozygotes as a whole showed increased levels of .alpha.1-antitrypsin (142 .+-. 39%, P < 0.01), indicating systemic consequences of the deficiency and reduced binding (.+-. 50%) of .alpha.2-antiplasmin to fibrin. Six exhibited a mild hemorrhagic diathesis for which no explanation was provided by routine screening of coagulation and platelet functions; also, within the group of heterozygotes, the occurrence of the bleeding tendency did not correlate with differences in residual .alpha.2-antiplasmin levels and functions. Not only the absence of .alpha.2-antiplasmin but also a reduction in its plasma level to .+-. 60% of normal may predispose to a hemorrhagic diathesis.This publication has 23 references indexed in Scilit:
- Cl-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: Its relation to vascular activator in blood and its role in euglobulin fibrinolysisThrombosis Research, 1978
- FAST-ACTING PLASMIN INHIBITOR IN HUMAN-PLASMA1978
- DETERMINATION OF PREKALLIKREIN IN HUMAN-PLASMA - OPTIMAL CONDITIONS FOR ACTIVATING PREKALLIKREIN1978
- Protease inhibitors and human plasmin: Interaction in a whole plasma systemBiochemical and Biophysical Research Communications, 1977
- The behavior of alpha2-plasmin inhibitor in fibrinolytic states.Journal of Clinical Investigation, 1977
- Inhibition of plasminogen binding to fibrin by α2-plasmin inhibitorThrombosis Research, 1977
- Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.Journal of Biological Chemistry, 1976
- Identification and Some Properties of a New Fast‐Reacting Plasmin Inhibitor in Human PlasmaEuropean Journal of Biochemistry, 1976
- Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasmaThrombosis Research, 1976
- Antithrombin III, heparin cofactor and antifactor Xa in a clinical materialThrombosis Research, 1976